Furthermore, studies in ovarian 57, prostate 48 and hepatocellular carcinoma 24 showed loss of PTPN13 expression in tumor versus normal tissues, in high grade versus low grade tumors, and a correlation between PTPN13 expression and favorable prognosis, respectively. This evidence concerns the gene PTPN13 and neoplasm.